Skip to main content
Published: 2019-08-23 11:07 | Updated: 2019-08-27 10:17

The Swedish Society of Medicine awards ”Maternal Glycemic Control in Type 1 Diabetes and the Risk of Preterm Birth” the Alvarenga Prize 2019 for best medical paper

The paper's motto was: ”Among women with diabetes and high HbA1c, there is a risk that the fetus too early the outside world will see”

The winning study was led by Professor Jonas F Ludvigsson, Department of Medical Epidemiology and Biostatistics, KI, and shows that pregnant women with type 1 diabetes are at increased risk of pregnancy complications, including preterm birth. With increasing HbA1c the risk of preterm birth increased further.

The authors have decided to donate the prize money 50 000 SEK to Medicins Sans Frontieres - MSF. 

– It is a great honour to be awarded the Alvarenga Prize. We will donate the prize money to Medicins Sans Frontieres and we support their work for pregnant women, newborns, and malaria control in Congo-Kinshasa, says professor Jonas F Ludvigsson. To reach the Agenda 2030 goals we must work relentlessly to prevent deaths in women and children, and one way is to stop malaria.

Maternal Glycemic Control in Type 1 Diabetes and the Risk for Preterm Birth: A Population-Based Cohort Study.
Ludvigsson JF, Neovius M, Söderling J, Gudbjörnsdottir S, Svensson AM, Franzén S, et al
Ann. Intern. Med. 2019 Apr;():

For more information, please contact Jonas or read more on the Swedish website of Svenska Läkaresällskapet.